SFE Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$405K Sell
2,131
-37
-2% -$6.36K 0.05% 115
2026
Q1
$366K Sell
2,168
-115
-5% -$19.7K 0.06% 114
2025
Q4
$385K Buy
2,283
+37
+2% +$6.01K 0.06% 115
2025
Q3
$324K Sell
2,246
-38
-2% -$5.19K 0.05% 119
2025
Q2
$289K Buy
2,284
+13
+0.6% +$1.6K 0.05% 123
2025
Q1
$291K Sell
2,271
-90
-4% -$12.2K 0.06% 118
2024
Q4
$312K Sell
2,361
-239
-9% -$33.6K 0.07% 97
2024
Q3
$379K Sell
2,600
-169
-6% -$24.5K 0.08% 101
2024
Q2
$380K Buy
2,769
+88
+3% +$11.7K 0.08% 100
2024
Q1
$368K Buy
2,681
+23
+0.9% +$3.14K 0.08% 109
2023
Q4
$361K Sell
2,658
-145
-5% -$17.7K 0.09% 100
2023
Q3
$343K Sell
2,803
-744
-21% -$94.6K 0.1% 104
2023
Q2
$450K Buy
3,547
+4
+0.1% +$520 0.13% 97
2023
Q1
$460K Sell
3,543
-69
-2% -$9.03K 0.14% 92
2022
Q4
$484K Sell
3,612
-484
-12% -$62.5K 0.15% 92
2022
Q3
$479K Buy
4,096
+219
+6% +$27.2K 0.15% 92
2022
Q2
$456K Sell
3,877
-1
-0% -$119 0.14% 94
2022
Q1
$505K Buy
+3,878
New +$505K 0.13% 96

Other funds holding IBB

SFE Investment Counsel's IBB Position: Q2 2026 in Review

SFE Investment Counsel reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q2 2026, selling an estimated $6.36K and leaving 2,131 shares worth $405K. The position accounts for 0.05% of the portfolio, ranked #115.

SFE Investment Counsel first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. The position peaked at $505K in Q1 2022. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • SFE Investment Counsel held 2,131 shares of iShares Biotechnology ETF worth $405K as of Q2 2026.
  • SFE Investment Counsel sold 37 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.36K.
  • iShares Biotechnology ETF made up 0.05% of SFE Investment Counsel's portfolio in Q2 2026, its #115 holding.
  • SFE Investment Counsel first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
  • SFE Investment Counsel's iShares Biotechnology ETF position peaked at $505K in Q1 2022.
  • 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SFE Investment Counsel's 13F filing for Q2 2026, filed 5 Aug 2026.